Research Article
[Retracted] Value of CT Radiomics and Clinical Features in Predicting Bone Metastases in Patients with NSCLC
Table 1
Patients’ characteristics and detailed information.
| | Characteristics | Osseous metastasis (N = 144) | No osseous metastasis (N = 51) | χ 2 | value |
| | Gender, n (%) | Male | 104 (53.3%) | 28 (14.4%) | 5.166 | 0.023 | | Female | 40 (20.5%) | 23 (11.8%) |
| | Age/year, n (%) | 30–45 | 9 (4.6%) | 1 (0.5%) | 2.532 | 0.47 | | 45–60 | 56 (28.6%) | 25 (12.8%) | | 60–75 | 67 (34.4%) | 21 (10.8%) | | ＞75 | 12 (6.2%) | 4 (2.1%) |
| | Histology | Squamous carcinoma | 14 (7.2%) | 12 (6.2%) | 7.055 | 0.029 | | Adenocarcinoma | 127 (65.1%) | 39 (20%) | | Not classified | 3 (1.5%) | — |
| | Smoking history | Yes | 48 (24.6%) | 18 (9.2%) | 0.065 | 0.799 | | No | 96 (49.2%) | 33 (16.9%) |
| | Family history | Yes | 7 (3.6%) | 3 (1.5%) | 0.081 | 0.776 | | No | 137 (70.3%) | 48 (24.6) |
| | Blood calcium | Reduce level 1 | 28 (14.4%) | 4 (2.1%) | 5.777 | 0.123 | | Reduce level 2 | 9 (4.6%) | 2 (1.0%) | | Reduce level 3 | 3 (1.5%) | — | | Normal | 104 (53.3%) | 45 (23.1%) |
| | Blood CEA | 1 | 105 (53.8%) | 9 (4.6%) | 47.375 | 0.001 | | 0 | 39 (20.0%) | 42 (21.5%) |
| | Blood NSE | 1 | 64 (32.8%) | 11 (5.6%) | 8.327 | 0.004 | | 0 | 80 (41.0%) | 40 (20.5%) |
| | Blood Cyfra21-1 | 1 | 107 (54.9%) | 18 (9.2%) | 24.908 | 0.001 | | 0 | 37 (19.0%) | 33 (16.9%) |
| | Blood ProGRP | 1 | 42 (21.5%) | 2 (1.0%) | 13.737 | 0.001 | | 0 | 102 (52.3%) | 49 (25.1%) |
| | Blood SCC | 1 | 39 (20.0%) | 11 (5.6%) | 0.601 | 0.438 | | 0 | 105 (53.8%) | 40 (20.5%) |
|
|
